ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,730,107, issued on Sept. 8.

"Reagent composition for immunophenotyping of B lymphoblastic leukemia/lymphoma and use thereof" was invented by Yanrong Liu (Beijing) and Yazhe Wang (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a reagent composition for immunophenotyping and MRD monitoring of B lymphoblastic leukemia/lymphoma (B-ALL/LBL). The reagent composition includes a 20-antibody combination. In the present disclosure, the antibody combination, the fluorescent labeling combination for the corresponding antibody, and the result interpretation methods are optimized. It only needs to use 20 kinds of antibodies in a single tube of cel...